Overview

A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin

Status:
Completed

Trial end date:
2009-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study was to assess the efficacy of adding Azopt dosed three times a day to Xalatan as compared to that of adding placebo to Xalatan in patients with elevated intraocular pressure.

Phase:

Phase 4

Details

Lead Sponsor:

Alcon Research

Treatments:

Brinzolamide
Latanoprost
Ophthalmic Solutions
Pharmaceutical Solutions